Prostate Cancer Clinical Trials

Showing 1741-1760 of 2,150 trials

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

NCT00033605

RATIONALE: Octreotide may be effective in preventing or controlling diarrhea in patients who are undergoing radiation therapy to the pelvis. It is not yet known whether octreotide is effective for diarrhea. PURPOSE: Randomized phase III trial to determine the effectiveness of octreotide in preventing diarrhea in patients who are undergoing radiation therapy to the pelvis.

Cervical CancerColorectal CancerDiarrhea+8 more

Alliance for Clinical Trials in Oncology130 participantsStarted Apr 2002

COMPLETEDPhase 2

Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate

NCT00006214

RATIONALE: Chemoprevention therapy is the use of certain drugs such as flutamide to try to prevent the development of cancer. Flutamide may be effective in the prevention of prostate cancer. PURPOSE: Randomized clinical trial to study the effectiveness of flutamide in preventing prostate cancer in patients who have neoplasia of the prostate.

Prostate Cancer

Alliance for Clinical Trials in Oncology63 participantsStarted Aug 2000

Scottsdale, Arizona, United States • Peoria, Illinois, United States • Urbana, Illinois, United States +20 more locations

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate

Related Searches

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy

A Prospective Randomized Trial of Two Different Prostate Biopsy Schemes

Registry and Database Lap Prostatectomy

PET-CT/MRI in the Radiotherapy for Prostate Cancer

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer

Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

Effects of ASA on Prostate Tissue

Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy

Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer

Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer

F-choline PET in Early Response Assessment for Castration Resistant Prostatic Cancer

Volume Controlled Ventilation vs Autoflow-volume Controlled Ventilation

Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT)

Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination